EP2575142A1 - Method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system - Google Patents
Method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system Download PDFInfo
- Publication number
- EP2575142A1 EP2575142A1 EP11401600A EP11401600A EP2575142A1 EP 2575142 A1 EP2575142 A1 EP 2575142A1 EP 11401600 A EP11401600 A EP 11401600A EP 11401600 A EP11401600 A EP 11401600A EP 2575142 A1 EP2575142 A1 EP 2575142A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- electromagnetic valve
- flowing
- enter
- total solution
- buffer tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 12
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 32
- 230000002285 radioactive effect Effects 0.000 title claims description 12
- 239000003814 drug Substances 0.000 title claims description 11
- 239000000126 substance Substances 0.000 title claims description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- 239000012530 fluid Substances 0.000 claims description 27
- 238000005406 washing Methods 0.000 claims description 24
- 238000004140 cleaning Methods 0.000 claims description 21
- 238000011001 backwashing Methods 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 7
- 239000002912 waste gas Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 5
- 230000001965 increasing effect Effects 0.000 abstract description 17
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000035484 reaction time Effects 0.000 abstract description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
Definitions
- the present invention relates to a radioactive medicine synthesis system; more particularly, relates to improving purity and yield of chemical product in an automatic radioactive medicine synthesis system.
- Nuclear medicine uses affinitive column for adhesion of target medicine to obtain product after washing and eluting.
- iodine isotope would process radioiodination in a buffer containing an oxidant.
- yield of target and purity of radioactive chemical medicine are affected by the volume of solution; time for oxidation; and arrangement of adhesion, washing and eluting processes.
- the yield and purity may become bad with high cost and the product obtained may become useless.
- the source has to be increased. But, following the increase in source, its volume is increased too. As a result, the yield and purity are still not increased or even decreased.
- a prior art separates the adhesion process and the washing process to reduce pollution of impurities.
- the prior art is automated. The operators only have to take the column manually for washing at the final stage. However, the activity of the column may be still high, the pollution may happen to the operators or there may be a chance for operation mistake in the time before washing.
- the easiest way for increasing the chemical production is to increase the volume of the reactants. But, in fact, it is not so simple. For example, the total volume for the reactions is critical. The reaction of radioiodination is processed in a liquid state and some reaction solutions can not be condensed, so that the yield may not be increased following the increase of the total reaction volume. Besides, radioiodination may contains some incomplete reactions so that some unreacted iodine will be left over. Purification has to be done to the product through processes of adhesion (of the product), washing and elution with an affinitive column, where the adhesion process includes processes of repeated back-and-forth flowing through the column to increase efficiency of adhesion.
- reaction solution filled in the column has a volume smaller than the total reaction volume, some problems may occur in the automatic system, even though an adhesion batch may be designed in theory. Because the column has a small diameter and the liquid has surface tension, incomplete adhesion may happen during the repeated flowing processes and some waste solution may be generated and discharged.
- the main purpose of the present invention is to increase a number of target reaction containers from one into many for increasing reaction volume coordinated with increased reaction times and, by modifying an affinitive column of an automatic synthesis system, to increase production in a single batch conformed to quality check specifications.
- the main purpose of the present invention is provide an automatic way to separate adhesion process and washing process by switching electromagnetic valves coordinated with different sizes of buffer tubes for increasing production and reducing cost
- the present invention is a method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, comprising steps of: (a) washing by: inputting a total solution of total solution by nitrogen gas to be flown through a second electromagnetic valve, a first electromagnetic valve and a fourth electromagnetic valve to enter into a first buffer tube; flowing said total solution through a sixth electromagnetic valve to enter an adhesion column to process adhesion; flowing said total solution through an eighth electromagnetic valve and a seventh electromagnetic valve to enter a second buffer tube; flowing a waste gas through a fifth electromagnetic valve and a third electromagnetic valve to be discharged; and staying said total solution in said second buffer tube; (b) backwashing by: flowing nitrogen gas through said second electromagnetic valve, said third electromagnetic valve and said fifth electromagnetic valve to push out said total solution in said second buffer tube; flowing said total solution through said seventh electromagnetic valve and said eighth electromagnetic valve to enter said adhesion column to process adhesion; flowing said total solution through said sixth electromagnetic valve to enter said first buffer tube; and flowing a waste gas through said fourth electromagnetic
- FIG.1 is a structural view showing devices used in a preferred embodiment according to the present invention.
- the present invention is a method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, where an original chemical reaction are divided into multiple reactions with adhesions processed after the multiple reactions; and where the adhesions have a total solution flowing back and forth along an adhesion column 1 several times for enhancing adhesion efficiency. Since the total solution has a big volume, the adhesion column 1 is separately added with a buffer tube 21,22 at each end of the adhesion column 1 for guiding the flowing of the total solution coordinated with a plurality of three-way electromagnetic valves 31 ⁇ 39.
- the column For removing unreacted radioactive iodine, the column must be cleaned.
- the present invention added two more buffer tubes 23,24 for washing and backwashing to separate processes of adhesion and washing for improving washing effect with the coordination of the three-way electromagnetic valves 31 ⁇ 39.
- FIG.2 to FIG.7 are views showing processes of washing with adhesion, backwashing with adhesion, discharging reaction solutions, backwashing, washing and eluting out product.
- the present invention comprises the following steps:
- the first to the ninth electromagnetic valves 31 ⁇ 39 are three-way electromagnetic valves; and, the first and the second buffer tubes 21,22 have diameters and volumes bigger than the third and the fourth buffer tubes 23,24.
- the present invention increases a number of target reaction containers from one into many (e.g. three) for increasing reaction volume coordinated with increased reaction times.
- An affinitive column of an automatic synthesis system is modified for increasing production in a single batch conformed to quality check specifications.
- the present invention separates a chemical reaction into many reactions for repeatedly processing original reactions to avoid reducing yield on increasing reaction volume.
- the present invention adds two plastic tubes at head and tail ends of the column to be used as buffer tubes for not only processing adhesion several times but also for solving the problem of incomplete adhesion for reaction solution owing to surface tension (i.e. waste solution).
- the present invention adds two empty columns at head and tail ends of the column to be used as buffer tubes to separate adhesion process and washing process with coordination of electromagnetic valves for controlling to obtain products conformed to quality check specifications.
- the present invention is a method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, where, in an automatic way, adhesion process and washing process are separated by switching electromagnetic valves coordinated with different sizes of buffer tubes for increasing production and reducing cost.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
Description
- The present invention relates to a radioactive medicine synthesis system; more particularly, relates to improving purity and yield of chemical product in an automatic radioactive medicine synthesis system.
- Nuclear medicine uses affinitive column for adhesion of target medicine to obtain product after washing and eluting. However, iodine isotope would process radioiodination in a buffer containing an oxidant. Hence, yield of target and purity of radioactive chemical medicine are affected by the volume of solution; time for oxidation; and arrangement of adhesion, washing and eluting processes. Thus, the yield and purity may become bad with high cost and the product obtained may become useless. For increasing production, the source has to be increased. But, following the increase in source, its volume is increased too. As a result, the yield and purity are still not increased or even decreased.
- A prior art separates the adhesion process and the washing process to reduce pollution of impurities. To avoid operators being seriously polluted by the radioactive source during the processes, the prior art is automated. The operators only have to take the column manually for washing at the final stage. However, the activity of the column may be still high, the pollution may happen to the operators or there may be a chance for operation mistake in the time before washing.
- Another prior art, Automated system for formulating radiopharmaceuticals, automates the purification of isotope washed from a germanium (Ge) / gallium (Ga) generator. The product obtained from the generator is a water solution and is not radioactively synthesized. It does not have buffer tubes having different sizes; have simple adhesion and washing processes; and detects purity of nuclei instead of purity of radioactive chemical medicine.
- In theory, the easiest way for increasing the chemical production is to increase the volume of the reactants. But, in fact, it is not so simple. For example, the total volume for the reactions is critical. The reaction of radioiodination is processed in a liquid state and some reaction solutions can not be condensed, so that the yield may not be increased following the increase of the total reaction volume. Besides, radioiodination may contains some incomplete reactions so that some unreacted iodine will be left over. Purification has to be done to the product through processes of adhesion (of the product), washing and elution with an affinitive column, where the adhesion process includes processes of repeated back-and-forth flowing through the column to increase efficiency of adhesion. However, the reaction solution filled in the column has a volume smaller than the total reaction volume, some problems may occur in the automatic system, even though an adhesion batch may be designed in theory. Because the column has a small diameter and the liquid has surface tension, incomplete adhesion may happen during the repeated flowing processes and some waste solution may be generated and discharged.
- Hence, the prior arts do not fulfill all users' requests on actual use.
- The main purpose of the present invention is to increase a number of target reaction containers from one into many for increasing reaction volume coordinated with increased reaction times and, by modifying an affinitive column of an automatic synthesis system, to increase production in a single batch conformed to quality check specifications.
- The main purpose of the present invention is provide an automatic way to separate adhesion process and washing process by switching electromagnetic valves coordinated with different sizes of buffer tubes for increasing production and reducing cost
- To achieve the above purposes, the present invention is a method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, comprising steps of: (a) washing by: inputting a total solution of total solution by nitrogen gas to be flown through a second electromagnetic valve, a first electromagnetic valve and a fourth electromagnetic valve to enter into a first buffer tube; flowing said total solution through a sixth electromagnetic valve to enter an adhesion column to process adhesion; flowing said total solution through an eighth electromagnetic valve and a seventh electromagnetic valve to enter a second buffer tube; flowing a waste gas through a fifth electromagnetic valve and a third electromagnetic valve to be discharged; and staying said total solution in said second buffer tube; (b) backwashing by: flowing nitrogen gas through said second electromagnetic valve, said third electromagnetic valve and said fifth electromagnetic valve to push out said total solution in said second buffer tube; flowing said total solution through said seventh electromagnetic valve and said eighth electromagnetic valve to enter said adhesion column to process adhesion; flowing said total solution through said sixth electromagnetic valve to enter said first buffer tube; and flowing a waste gas through said fourth electromagnetic valve and said first electromagnetic valve to be discharged; (c) discharging reaction solution by: flowing nitrogen gas through said second electromagnetic valve, said first electromagnetic valve and said fourth electromagnetic valve to push out said total solution stayed in said first buffer tube; flowing said total solution through said sixth electromagnetic valve, said eighth electromagnetic valve and a ninth electromagnetic valve to be discharged; (d) backwashing by: flowing a cleaning fluid through said second electromagnetic valve, said third electromagnetic valve and said fifth electromagnetic valve to enter a fourth buffer tube; flowing said cleaning fluid through said seventh electromagnetic valve and said eighth electromagnetic valve to enter said adhesion column to wash out impurities; flowing said cleaning fluid through said sixth electromagnetic valve to enter a third buffer tube; and flowing said cleaning fluid through said fourth electromagnetic valve and said first electromagnetic valve to be discharged; (e) washing by: flowing a cleaning fluid through said second electromagnetic valve, said first electromagnetic valve and said fourth electromagnetic valve to enter said third buffer tube; flowing said cleaning fluid through said sixth electromagnetic valve to enter said adhesion column to wash out impurities; and flowing said cleaning fluid through said eighth electromagnetic valve and said ninth electromagnetic valve to be discharged; and (f) eluting out product by: flowing an eluting fluid through said second electromagnetic valve, said first electromagnetic valve and said fourth electromagnetic valve to enter said third buffer tube; flowing an eluting fluid through said sixth electromagnetic valve to enter said adhesion column to elute out a product; and flowing said product through said eighth electromagnetic valve and said ninth electromagnetic valve to flow out said product. Accordingly, a novel method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system is obtained.
- The present invention will be better understood from the following detailed description of the preferred embodiment according to the present invention, taken in conjunction with the accompanying drawings, in which
-
FIG.1 is the structural view showing the devices used in the preferred embodiment according to the present invention; -
FIG.2 is the view showing the process of washing with adhesion; -
FIG.3 is the view showing the process of backwashing with adhesion; -
FIG.4 is the view showing the process of discharging the total solution; -
FIG.5 is the view showing the process of backwashing; -
FIG.6 is the view showing the process of washing; and -
FIG.7 is the view showing the process of eluting out product. - The following description of the preferred embodiment is provided to understand the features and the structures of the present invention.
- Please refer to
FIG.1 , which is a structural view showing devices used in a preferred embodiment according to the present invention. As shown in the figure, the present invention is a method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, where an original chemical reaction are divided into multiple reactions with adhesions processed after the multiple reactions; and where the adhesions have a total solution flowing back and forth along anadhesion column 1 several times for enhancing adhesion efficiency. Since the total solution has a big volume, theadhesion column 1 is separately added with a 21,22 at each end of thebuffer tube adhesion column 1 for guiding the flowing of the total solution coordinated with a plurality of three-wayelectromagnetic valves 31∼39. - For removing unreacted radioactive iodine, the column must be cleaned. In an automatic synthesis system, the present invention added two
23,24 for washing and backwashing to separate processes of adhesion and washing for improving washing effect with the coordination of the three-waymore buffer tubes electromagnetic valves 31∼39. - Please refer to
FIG.2 to FIG.7 , which are views showing processes of washing with adhesion, backwashing with adhesion, discharging reaction solutions, backwashing, washing and eluting out product. As shown in the figures, the present invention comprises the following steps: - (a) Washing for adhesion: A total solution of reaction solutions is flown for adhesion with column. In
FIG.2 , a total solution of reaction solutions is pushed by nitrogen gas to be flown through a secondelectromagnetic valve 32, a firstelectromagnetic valve 31 and a fourthelectromagnetic valve 34 to enter into afirst buffer tube 21. Then, the total solution is flown through a sixthelectromagnetic valve 36 to enter anadhesion column 1 to process adhesion. Then, the total solution is flown through an eighthelectromagnetic valve 38 and a seventhelectromagnetic valve 37 to enter asecond buffer tube 22. Then, a waste gas is flown through a fifthelectromagnetic valve 35 and a thirdelectromagnetic valve 33 to be discharged. The total solution is stayed in thesecond buffer tube 22. - (b) Backwashing for adhesion: The total solution stayed in the
second buffer tube 22 is flown for backwashing for adhesion with column. InFIG.3 , nitrogen gas is flown through the secondelectromagnetic valve 32, the thirdelectromagnetic valve 33 and the fifthelectromagnetic valve 35 to push out the total solution stayed in thesecond buffer tube 22. Then, the total solution is flown through the seventhelectromagnetic valve 37 and the eighthelectromagnetic valve 38 to enter theadhesion column 1 for processing adhesion. Then, the total solution is flown through the sixthelectromagnetic valve 36 to enter thefirst buffer tube 21. Then, a waste gas is flown through the fourthelectromagnetic valve 34 and the firstelectromagnetic valve 31 to be discharged. - (c) Discharging reaction solution: Nitrogen gas is flown through the second
electromagnetic valve 32, the firstelectromagnetic valve 31 and the fourthelectromagnetic valve 34 to push out the total solution stayed in thefirst buffer tube 21. Then, the total solution is flown through the sixthelectromagnetic valve 36, the eighthelectromagnetic valve 38 and a ninthelectromagnetic valve 39 to be discharged. - (d) Backwashing: A cleaning fluid is flown through the second
electromagnetic valve 32, the thirdelectromagnetic valve 33 and the fifthelectromagnetic valve 35 to enter afourth buffer tube 24. Then, the cleaning fluid is flown through the seventhelectromagnetic valve 37 and the eighthelectromagnetic valve 38 to enter theadhesion column 1 to wash out impurities. Then, the cleaning fluid is flown through the sixthelectromagnetic valve 36 to enter athird buffer tube 23. Then, the cleaning fluid is flown through the fourthelectromagnetic valve 34 and the firstelectromagnetic valve 31 to be discharged. - (e) Washing: A cleaning fluid is flown through the second
electromagnetic valve 32, the firstelectromagnetic valve 31 and the fourthelectromagnetic valve 34 to enter thethird buffer tube 23. Then, the cleaning fluid is flown through the sixthelectromagnetic valve 36 to enter theadhesion column 1 for washing out impurities. Then, the cleaning fluid is flown through the eighthelectromagnetic valve 38 and the ninthelectromagnetic valve 39 to be discharged. - (f) Eluting: An eluting fluid is flown through the second
electromagnetic valve 32, the firstelectromagnetic valve 31 and the fourthelectromagnetic valve 34 to enter thethird buffer tube 23. Then, the eluting fluid is flown through the sixthelectromagnetic valve 36 to enter theadhesion column 1 for eluting out a product. Then, the product is flown through the eighthelectromagnetic valve 38 and the ninthelectromagnetic valve 39 to be flown out. - The first to the ninth
electromagnetic valves 31∼39 are three-way electromagnetic valves; and, the first and the 21,22 have diameters and volumes bigger than the third and thesecond buffer tubes 23,24.fourth buffer tubes - The present invention increases a number of target reaction containers from one into many (e.g. three) for increasing reaction volume coordinated with increased reaction times. An affinitive column of an automatic synthesis system is modified for increasing production in a single batch conformed to quality check specifications.
- Hence, the present invention separates a chemical reaction into many reactions for repeatedly processing original reactions to avoid reducing yield on increasing reaction volume. Besides, the present invention adds two plastic tubes at head and tail ends of the column to be used as buffer tubes for not only processing adhesion several times but also for solving the problem of incomplete adhesion for reaction solution owing to surface tension (i.e. waste solution). Furthermore, the present invention adds two empty columns at head and tail ends of the column to be used as buffer tubes to separate adhesion process and washing process with coordination of electromagnetic valves for controlling to obtain products conformed to quality check specifications.
- To sum up, the present invention is a method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, where, in an automatic way, adhesion process and washing process are separated by switching electromagnetic valves coordinated with different sizes of buffer tubes for increasing production and reducing cost.
- The preferred embodiment herein disclosed is not intended to unnecessarily limit the scope of the disclosure. Therefore, simple modifications or variations belonging to the equivalent of the scope of the claims and the instructions disclosed herein for a patent are all within the scope of the present invention.
Claims (3)
- A method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system, comprising steps of:(a) washing by: inputting a total solution of total solution by nitrogen gas to be flown through a second electromagnetic valve, a first electromagnetic valve and a fourth electromagnetic valve to enter into a first buffer tube; flowing said total solution through a sixth electromagnetic valve to enter an adhesion column to process adhesion; flowing said total solution through an eighth electromagnetic valve and a seventh electromagnetic valve to enter a second buffer tube; flowing a waste gas through a fifth electromagnetic valve and a third electromagnetic valve to be discharged; and staying said total solution in said second buffer tube;(b) backwashing by: flowing nitrogen gas through said second electromagnetic valve, said third electromagnetic valve and said fifth electromagnetic valve to push out said total solution in said second buffer tube; flowing said total solution through said seventh electromagnetic valve and said eighth electromagnetic valve to enter said adhesion column to process adhesion; flowing said total solution through said sixth electromagnetic valve to enter said first buffer tube; and flowing a waste gas through said fourth electromagnetic valve and said first electromagnetic valve to be discharged;(c) discharging reaction solution by: flowing nitrogen gas through said second electromagnetic valve, said first electromagnetic valve and said fourth electromagnetic valve to push out said total solution stayed in said first buffer tube; flowing said total solution through said sixth electromagnetic valve, said eighth electromagnetic valve and a ninth electromagnetic valve to be discharged;(d) backwashing by: flowing a cleaning fluid through said second electromagnetic valve, said third electromagnetic valve and said fifth electromagnetic valve to enter a fourth buffer tube; flowing said cleaning fluid through said seventh electromagnetic valve and said eighth electromagnetic valve to enter said adhesion column to wash out impurities; flowing said cleaning fluid through said sixth electromagnetic valve to enter a third buffer tube; and flowing said cleaning fluid through said fourth electromagnetic valve and said first electromagnetic valve to be discharged;(e) washing by: flowing a cleaning fluid through said second electromagnetic valve, said first electromagnetic valve and said fourth electromagnetic valve to enter said third buffer tube; flowing said cleaning fluid through said sixth electromagnetic valve to enter said adhesion column to wash out impurities; and flowing said cleaning fluid through said eighth electromagnetic valve and said ninth electromagnetic valve to be discharged; and(f) eluting out product by: flowing an eluting fluid through said second electromagnetic valve, said first electromagnetic valve and said fourth electromagnetic valve to enter said third buffer tube; flowing said eluting fluid through said sixth electromagnetic valve to enter said adhesion column to elute out a product; and flowing said product through said eighth electromagnetic valve and said ninth electromagnetic valve to be flown out.
- The method according to claim 1 ,
wherein said first to said ninth electromagnetic valves are three-way electromagnetic valves. - The method according to claim 1,
wherein said first and said second buffer tubes have diameters and volumes bigger than said third and said fourth buffer tubes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20110401600 EP2575142B1 (en) | 2011-09-27 | 2011-09-27 | Method of Improving Purity and Yield of Chemical Product in an Automatic Radioactive Medicine Synthesis System |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20110401600 EP2575142B1 (en) | 2011-09-27 | 2011-09-27 | Method of Improving Purity and Yield of Chemical Product in an Automatic Radioactive Medicine Synthesis System |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2575142A1 true EP2575142A1 (en) | 2013-04-03 |
| EP2575142B1 EP2575142B1 (en) | 2015-04-01 |
Family
ID=44992841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20110401600 Not-in-force EP2575142B1 (en) | 2011-09-27 | 2011-09-27 | Method of Improving Purity and Yield of Chemical Product in an Automatic Radioactive Medicine Synthesis System |
Country Status (1)
| Country | Link |
|---|---|
| EP (1) | EP2575142B1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5368736A (en) * | 1993-07-26 | 1994-11-29 | The United States Of America As Represented By The United States Department Of Energy | Process for the separation and purification of yttrium-90 for medical applications |
| WO2003000376A1 (en) * | 2001-06-22 | 2003-01-03 | Pg Research Foundation, Inc. | Automated radionuclide separation system and method |
| EP1772157A1 (en) * | 2005-10-06 | 2007-04-11 | Karl-Heinz Jansen | Modular assembly and synthesis method for the production of radiopharmaceuticals and nuclides |
| US20080035542A1 (en) * | 2006-08-14 | 2008-02-14 | Board Of Regents, The University Of Texas System | Automated system for formulating radiopharmaceuticals |
-
2011
- 2011-09-27 EP EP20110401600 patent/EP2575142B1/en not_active Not-in-force
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5368736A (en) * | 1993-07-26 | 1994-11-29 | The United States Of America As Represented By The United States Department Of Energy | Process for the separation and purification of yttrium-90 for medical applications |
| WO2003000376A1 (en) * | 2001-06-22 | 2003-01-03 | Pg Research Foundation, Inc. | Automated radionuclide separation system and method |
| EP1772157A1 (en) * | 2005-10-06 | 2007-04-11 | Karl-Heinz Jansen | Modular assembly and synthesis method for the production of radiopharmaceuticals and nuclides |
| US20080035542A1 (en) * | 2006-08-14 | 2008-02-14 | Board Of Regents, The University Of Texas System | Automated system for formulating radiopharmaceuticals |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2575142B1 (en) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wellens et al. | A continuous ionic liquid extraction process for the separation of cobalt from nickel | |
| EP3283218B1 (en) | Regeneration of mixed bed resins | |
| US8920573B2 (en) | Method of improving purity and yield of chemical product in automatic radioactive medicine synthesis system | |
| EP2575142A1 (en) | Method of improving purity and yield of chemical product in an automatic radioactive medicine synthesis system | |
| CN104789782A (en) | BP price-adjusting, degassing and acid-adjusting integrated device and method in Purex process | |
| CN102031369A (en) | Method for extracting uranium by using ion exchange fixed tower under alternate Ph condition | |
| WO2020112222A3 (en) | Liquid-liquid mass transfer process and apparatus | |
| CN102161542A (en) | Method and device for precisely processing nuclear power station condensation water | |
| JP5483958B2 (en) | Method for producing tetraalkylammonium hydroxide | |
| WO2013055458A3 (en) | Economical production of isotopes using quantized target irradiation | |
| CN109225355A (en) | A kind of continuous ionic exchange process removing inorganic salts and used system | |
| CN205761055U (en) | A kind of device of fixed bed hydrogenation refined caprolactam | |
| TWI444183B (en) | An improved radiochemical purity and yield method for automated synthesis and purification system | |
| CN203663849U (en) | Catalyst recycle and recovery device | |
| CN103745758B (en) | A kind of feed process of radioactivity feed liquid | |
| CN204933436U (en) | Two autoclave continuous nitrification reaction unit | |
| CN201907986U (en) | Device for processing nickel-containing wastewater generated in preparation process of chemical hydrogenation catalyst by continuous adsorption and regenerative coupling | |
| CN213221051U (en) | Device for removing water-soluble impurities from organic extraction phase | |
| CN203426175U (en) | Copper bar cooling and washing device | |
| CN103922515A (en) | Comprehensive treatment device of stainless steel pickling wastewater | |
| WO2016105235A1 (en) | Reactor facility for producing an isotope product | |
| CN202116392U (en) | Precision processing device of condensation water of nuclear power station | |
| CN104862008A (en) | Continuous production system of environment-friendly rubber softener | |
| CN211585315U (en) | System for continuously removing cations in 3-hydroxy-1, 3, 5-pentanedioic acid | |
| CN110085513A (en) | A kind of silicon wafer cleaning method and cleaning device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20110929 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: G21G 1/00 20060101AFI20140924BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20141022 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 719499 Country of ref document: AT Kind code of ref document: T Effective date: 20150515 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011015206 Country of ref document: DE Effective date: 20150521 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20150401 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 719499 Country of ref document: AT Kind code of ref document: T Effective date: 20150401 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150701 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150803 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20150922 Year of fee payment: 5 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150702 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150801 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011015206 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: RO Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150401 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| 26N | No opposition filed |
Effective date: 20160105 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602011015206 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150927 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20160531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150930 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150927 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160401 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150930 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20160927 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110927 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160927 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 |